Jan 10, 2023

A new FDA-approved Alzheimer’s medicine slowed cognitive decline in patients

Posted by in categories: biotech/medical, neuroscience


Also known as lecanemab, Leqembi is the second drug of its kind – a medication that has been approved for treating Alzheimer’s disease. This type of medication targets the fundamental pathophysiology of the disease and is considered a significant development in the effort to successfully treat Alzheimer’s disease.

Leave a reply